1999
DOI: 10.1002/(sici)1098-2396(199901)31:1<5::aid-syn2>3.0.co;2-d
|Get access via publisher |Summarize |Cite
Tracers for imaging melanin with positron emission tomography
Abstract: The melanin binding properties of six radioligands were determined in vivo in the eyes of pigmented mice. Binding in the eyes of nonpigmented mice was used to assess nonmelanin binding characteristics. Of these radioligands, 3H-N-methylspiperone showed the best uptake and gave the best signal-to-noise ratio at all time points examined. Its binding appeared essentially irreversible. A PET study with 11C-N-methylspiperone was therefore carried out in a patient with a small ocular melanoma. Increased uptake of 11…
Search citation statements
Paper Sections
Select...
4
1
1
0
Citation Types
0
3
0
0
Year Published
2000
2011
Publication Types
Select...
4
1
1
Relationship
0
6
Authors
Journals
Cited by 6 publications
(3 citation statements)
References 38 publications
0
3
0
0
“…With this in mind, it seems reasonable to assume that treatment-related extinguished SUV may correlate to both local control and loss of ability to metastasize. Additionally, it should be considered that [ 18 F]FDG is relatively nonspecific for melanoma and that new melanoma-directed PET/CT radiopharmaceuticals will become available (38).…”
Section: Discussionmentioning
confidence: 99%
“…With this in mind, it seems reasonable to assume that treatment-related extinguished SUV may correlate to both local control and loss of ability to metastasize. Additionally, it should be considered that [ 18 F]FDG is relatively nonspecific for melanoma and that new melanoma-directed PET/CT radiopharmaceuticals will become available (38).…”
Section: Discussionmentioning
confidence: 99%
“…8 18 F-FDG-positron emission tomography (PET) studies of uveal melanomas revealed variable glucose consumption among ocular lesions, 9,10 thus enabling the visualization only of some larger-sized lesions. PET tracers, such as 11 C-N-methylspiperone, 11 possibly binding to melanin, are under investigation in ocular melanoma.…”
Section: Introductionmentioning
confidence: 99%
“…C-Methionine, 379 125 I-alpha-methyl-tyrosine (AMT), 18 F-DOPA, 380 18 F-FLT, 381 11 C-N-methylspiperone, 382 and radiolabeled alpha-melanocyte-stimulating hormone 383 are some of the new promising radiopharamaceuticals in the field of melanoma.…”
mentioning
confidence: 99%
